PAG
JAZZ icon

Private Advisor Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Private Advisor Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$486K Buy
2,571
+21
+0.8% +$3.67K ﹤0.01% 1879
2025
Q4 		$434K Sell
2,550
-197
-7% -$30.2K ﹤0.01% 1916
2025
Q3 		$362K Sell
2,747
-498
-15% -$59.7K ﹤0.01% 1961
2025
Q2 		$344K Sell
3,245
-21
-0.6% -$2.28K ﹤0.01% 1901
2025
Q1 		$405K Sell
3,266
-1,657
-34% -$216K ﹤0.01% 1714
2024
Q4 		$606K Sell
4,923
-2,793
-36% -$329K ﹤0.01% 1462
2024
Q3 		$860K Buy
7,716
+5,437
+239% +$596K 0.01% 1313
2024
Q2 		$243K Sell
2,279
-880
-28% -$96.8K ﹤0.01% 2031
2024
Q1 		$380K Buy
3,159
+192
+6% +$23.5K ﹤0.01% 1684
2023
Q4 		$365K Buy
2,967
+979
+49% +$122K ﹤0.01% 1661
2023
Q3 		$257K Sell
1,988
-484
-20% -$64.5K ﹤0.01% 1728
2023
Q2 		$306K Sell
2,472
-855
-26% -$115K ﹤0.01% 1618
2023
Q1 		$487K Buy
+3,327
New +$492K ﹤0.01% 1350
2022
Q4 		– Sell
-3,723
Closed -$496K – 1821
2022
Q3 		$496K Buy
3,723
+151
+4% +$23K 0.01% 1237
2022
Q2 		$557K Buy
3,572
+61
+2% +$9.39K 0.01% 1352
2022
Q1 		$547K Buy
+3,511
New +$510K ﹤0.01% 1383
2020
Q3 		– Sell
-127
Closed -$14K – 2535
2020
Q2 		$14K Buy
+127
New +$14K ﹤0.01% 2755
2018
Q3 		– Sell
-5,516
Closed -$951K – 1626
2018
Q2 		$951K Buy
+5,516
New +$902K 0.02% 500
2017
Q2 		– Sell
-1,525
Closed -$215K – 1426
2017
Q1 		$215K Buy
+1,525
New +$199K 0.01% 1238
2014
Q1 		– Sell
-7,075
Closed -$895K – 822
2013
Q4 		$895K Buy
+7,075
New +$732K 0.1% 247

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Private Advisor Group's JAZZ Position: Q1 2026 in Review

Private Advisor Group increased its Jazz Pharmaceuticals (JAZZ) stake by 0.82% in Q1 2026, buying an estimated $3.67K and bringing the position to 2,571 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

Private Advisor Group first reported a position in JAZZ in Q4 2013 and has held it in 20 quarters since. The position peaked at $951K in Q2 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Private Advisor Group held 2,571 shares of Jazz Pharmaceuticals worth $486K as of Q1 2026.
  • Private Advisor Group bought 21 Jazz Pharmaceuticals shares in Q1 2026, an estimated $3.67K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #1879 holding.
  • Private Advisor Group first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 20 quarters since.
  • Private Advisor Group's Jazz Pharmaceuticals position peaked at $951K in Q2 2018.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.